Cancers (Jun 2022)

Breast Cancer Genomics: Primary and Most Common Metastases

  • Caroline Bennett,
  • Caleb Carroll,
  • Cooper Wright,
  • Barbara Awad,
  • Jeong Mi Park,
  • Meagan Farmer,
  • Elizabeth (Bryce) Brown,
  • Alexis Heatherly,
  • Stefanie Woodard

DOI
https://doi.org/10.3390/cancers14133046
Journal volume & issue
Vol. 14, no. 13
p. 3046

Abstract

Read online

Specific genomic alterations have been found in primary breast cancer involving driver mutations that result in tumorigenesis. Metastatic breast cancer, which is uncommon at the time of disease onset, variably impacts patients throughout the course of their disease. Both the molecular profiles and diverse genomic pathways vary in the development and progression of metastatic breast cancer. From the most common metastatic site (bone), to the rare sites such as orbital, gynecologic, or pancreatic metastases, different levels of gene expression indicate the potential involvement of numerous genes in the development and spread of breast cancer. Knowledge of these alterations can, not only help predict future disease, but also lead to advancement in breast cancer treatments. This review discusses the somatic landscape of breast primary and metastatic tumors.

Keywords